88
68
Growth Score 88 in past quarter
-1 pts
Heat Score 68 in past quarter
22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
195700
ImpediMed designs and manufactures bioimpedance spectroscopy devices for breast cancer lymphedema prevention.
- Parmjot Bains: Managing Director and Chief Executive OfficerPast Role: Neuren Pharmaceuticals, Chief Executive Officer
- Erik Anderson: Managing Director and Chief Executive OfficerPast Role: Hologic, Division President, Breast and Skeletal Health